Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine | Zendy

Tao Tao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Reactivation of a BCG Vaccination Scar Following the First Dose of the Moderna COVID-19 Vaccine

Author(s) -

Tao Tao

Publication year - 2022

Publication title -

cutis

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.289

H-Index - 53

eISSN - 2326-6929

pISSN - 0011-4162

DOI - 10.12788/cutis.0470

Subject(s) - medicine , vaccination , covid-19 , pandemic , virology , bcg vaccine , attenuated vaccine , immunology , pathology , outbreak , disease , infectious disease (medical specialty) , biochemistry , chemistry , virulence , gene

The devastating effects of the COVID-19 pandemic have prompted rapid development and distribution of multiple vaccines. A 2-dose messenger RNA (mRNA) vaccine developed by Moderna (Moderna COVID-19 Vaccine) was approved in December 2020 for the prevention of COVID-19. We describe a case of BCG vaccination scar reactivation in a 48-year-old man after he received the first dose of the Moderna COVID-19 Vaccine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research